This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: The University of Arizona. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: Tally Milnes: Innovator in Pain Treatment
Introduction
Tally Milnes is an accomplished inventor based in Tucson, AZ (US). He has made significant contributions to the field of pain treatment through his innovative research and development of oligopeptides.
Latest Patents
Milnes holds 3 patents, with his latest invention focusing on Ang (1-7) derivative oligopeptides for the treatment of pain. This invention provides oligopeptides, particularly Ang-(1-7) derivatives, along with methods for their use and production. In one embodiment, these oligopeptides demonstrate higher blood-brain barrier penetration and/or in vivo half-life compared to the native Ang-(1-7). This advancement allows for a wide variety of clinical applications, including the treatment of cognitive dysfunction and pain.
Career Highlights
Milnes is affiliated with the University of Arizona, where he continues to push the boundaries of research in pain management. His work has garnered attention for its potential impact on clinical practices.
Collaborations
Some of his notable coworkers include Meredith Hay and John Konhilas, who contribute to the collaborative environment that fosters innovation in their research endeavors.
Conclusion
Tally Milnes is a pioneering inventor whose work in oligopeptides is paving the way for new treatments in pain management. His contributions are vital to advancing medical science and improving patient care.